Toluidine blue dye reveals oral cancers

Published on September 1, 2005 at 7:47 AM · No Comments

A team of Canadian scientists may have discovered a way to use a simple dye as a litmus test to identify abnormal areas of the mouth that may become cancers.

According to a study published in the September 1 issue of Cancer Research, the scientists found that lesions that took up the dye known as toluidine blue were six times more likely to become oral cancers.

The team also discovered that the dye-staining lesions contained molecular alterations that are linked to high risk of oral cancers -- even at early stages.

"In oral cavity lesions, tissue that stained positive with toluidine blue were more likely to advance to cancer than lesions that did not stain with the dye," said Miriam Rosin, Ph.D., Director of the BC Cancer Agency's British Columbia Oral Cancer Prevention Program and Professor, Simon Fraser University. Rosin is the senior author on the study, funded by the National Institute of Dental and Craniofacial Research, of the National Institutes of Health.

Toluidine blue is an accepted indicator of oral cancers, Rosin said. The current studies, however, demonstrate that the dye accurately predicts which pre-malignant lesions are likely to advance toward disease. Those lesions appear as white or, less frequently, red patches.

"The vast majority of those white patches are often from minor inflammation and irritation," Rosin said. Some, however, are inclined to become cancer--and are the ones targeted by this simple imaging technology.

In the study of 100 patients, Rosin and her colleagues learned that toluidine blue-stained lesions became squamous cell carcinomas more quickly than lesions that did not stain. The scientists also determined that dye-stained oral lesions were more likely to be aberrant not only at the gross tissue level but at the molecular genetic level as well. Toluidine blue was applied to lesions in the mouths of patients during dental visits to determine the value of the stain for imaging precancerous lesions.

"Oral premalignant lesions that stained with toluidine blue consistently contained loss of chromosomal genetic information," Rosin said. In patients with dye-stained lesions, Rosin and colleagues found a strong association with loss of genetic information, termed loss of heterozygosity (LOH), on one or more chromosomes.

"Patients with positively stained tissue had a higher incidence of LOH at multiple sites, including regions on chromosome arms 3p or 9p or both as well as on parts of other chromosomes" Rosin said. Rosin's Cancer Research article reports results from the initial phase of a long term study that followed 100 patients for 44 months. By the completion of the longitudinal study, Rosin and colleagues will monitor 400 patients.

The current report links the staining of cells with toluidine blue in mouth tissue to the higher risk of patients likely to develop squamous cell carcinomas. When biopsied, lesions that stained blue most often showed microscopic abnormal tissue development – dysplasia – that is associated with cancer risk.

The Rosin team then established that the dye-stained lesions had characteristic molecular alterations that are linked to higher risk for oral cancers -- even when the dye stained tissue is at an early stage, when dysplasia is minimal. Cells with molecular changes took up the blue dye before the lesion acquired extensive dysplasia. The findings are among the first steps in designing and implementing an imaging screening program that dentists and oral hygiene professionals can use to make first-line decisions about early stage biopsies and referrals for anti-cancer related care.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | עִבְרִית | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post